1 insider bought €12.3M of shares over the last 90 days, the latest filed 28 Aug 2026.
Bactiguard Holding AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. In the past year (18 October 2025 to 18 October 2026), 6 filings came from 2 insiders.
Only purchases show up on the open market, 4 purchases in all worth €12.8M, filed by 2 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 board member and 1 finance chief. One trade stands out by size: a purchase of €8.3M from Thomas von Koch, disclosed on 28 August 2026, or 16.5% of market capitalisation.
The clock since the last published purchase (28 August 2026) now reads 50 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade.
With 6 filings in twelve months, the company is quieter than the median of 7 filings across the 890 companies we follow on the same exchange. Our records for Bactiguard Holding AB go back to 2021, with 11 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
13 of 13 declarations
Bactiguard Holding AB is a company focused on developing solutions to prevent healthcare-associated infections. It offers medical products utilizing patented technology to reduce the risk of infections related to medical devices.
Purchases our model currently ranks for the recommendations list.
All recommendations